REG - Dr. Martens PLC - Director/PDMR Shareholding

Dr MartensAnnouncement

26/03/2025 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250326:nRSZ3089Ca&default-theme=true

RNS Number : 3089C  Dr. Martens PLC  26 March 2025

Dr. Martens plc (the "Company")

Director/PDMR Shareholding

Notification of Transaction by Director/Person Discharging Managerial
Responsibility

Dr. Martens plc (the "Company") announces that it has been notified of the
following transaction in the Company's Ordinary 1p shares undertaken on behalf
of a director and person discharging managerial responsibility ("PDMR").

 

On 25 March 2025, Giles Wilson, Chief Financial Officer, received a cash
payment pursuant to the buyout arrangements agreed in advance of his
appointment in May 2024, details of which were disclosed in the Company's 2024
Annual Report. In line with the Company's Remuneration Policy, one third of
the net amount payable was subsequently used to purchase shares which Giles is
required to hold for a minimum of two years.

The relevant notification, set out below, is provided in accordance with the
requirements of Article 19 of the Market Abuse Regulation.

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Giles Wilson
 2   Reason for the notification
 a)  Position/status                                              PDMR (Chief Financial Officer)
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Dr. Martens plc
 b)  LEI                                                          213800QPT8YM6NQZPH28
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of GBP 0.01

     Identification code

                                                                  ISIN: GB00BL6NGV24
 b)  Nature of the transaction                                    Purchase of Ordinary shares.
 c)  Price(s) and volume(s)                                       Price(s)  Volume(s)
                                                                  54.0083p  32,640
 d)  Aggregated information

- Aggregated volume

                                                            32,640

- Price

54.0083p

 e)  Date of the transaction                                      25 March 2025
 f)  Place of the transaction                                     XLON

d)

Aggregated information

 -  Aggregated volume

 -  Price

 

32,640

54.0083p

 

e)

Date of the transaction

25 March 2025

f)

Place of the transaction

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUNVKRVWUOURR